Elcheva I - Search Results

1

Global role of IGF2BP1 in controlling the expression of Wnt/β-catenin-regulated genes in colorectal cancer cells.

Singh V, Walter V, Elcheva I, Imamura Kawasawa Y, Spiegelman VS. Singh V, et al. Among authors: elcheva i. Front Cell Dev Biol. 2023 Sep 27;11:1236356. doi: 10.3389/fcell.2023.1236356. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37829185 Free PMC article.

2

Metabo-miR: miR-211 Regulates Mitochondrial Energy Metabolism in Vitiligo.

Spiegelman VS, Elcheva IA. Spiegelman VS, et al. J Invest Dermatol. 2017 Sep;137(9):1828-1830. doi: 10.1016/j.jid.2017.06.012. J Invest Dermatol. 2017. PMID: 28843294 Free article. Review.

3

Extracellular vesicle-dependent effect of RNA-binding protein IGF2BP1 on melanoma metastasis.

Ghoshal A, Rodrigues LC, Gowda CP, Elcheva IA, Liu Z, Abraham T, Spiegelman VS. Ghoshal A, et al. Oncogene. 2019 May;38(21):4182-4196. doi: 10.1038/s41388-019-0797-3. Epub 2019 Apr 1. Oncogene. 2019. PMID: 30936459 Free PMC article.

4

RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1.

Elcheva IA, Wood T, Chiarolanzio K, Chim B, Wong M, Singh V, Gowda CP, Lu Q, Hafner M, Dovat S, Liu Z, Muljo SA, Spiegelman VS. Elcheva IA, et al. Leukemia. 2020 May;34(5):1354-1363. doi: 10.1038/s41375-019-0656-9. Epub 2019 Nov 25. Leukemia. 2020. PMID: 31768017 Free PMC article.

5

Targeting RNA-binding proteins in acute and chronic leukemia.

Elcheva IA, Spiegelman VS. Elcheva IA, et al. Leukemia. 2021 Feb;35(2):360-376. doi: 10.1038/s41375-020-01066-4. Epub 2020 Nov 4. Leukemia. 2021. PMID: 33149266 Free PMC article.

6

The Role of cis- and trans-Acting RNA Regulatory Elements in Leukemia.

Elcheva IA, Spiegelman VS. Elcheva IA, et al. Cancers (Basel). 2020 Dec 20;12(12):3854. doi: 10.3390/cancers12123854. Cancers (Basel). 2020. PMID: 33419342 Free PMC article. Review.

7

IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment.

Elcheva IA, Gowda CP, Bogush D, Gornostaeva S, Fakhardo A, Sheth N, Kokolus KM, Sharma A, Dovat S, Uzun Y, Schell TD, Spiegelman VS. Elcheva IA, et al. Front Immunol. 2023 Jul 12;14:1224516. doi: 10.3389/fimmu.2023.1224516. eCollection 2023. Front Immunol. 2023. PMID: 37503349 Free PMC article.

8

A novel hiPSC-derived system for hematoendothelial and myeloid blood toxicity screens identifies compounds promoting and inhibiting endothelial-to-hematopoietic transition.

Elcheva I, Sneed M, Frazee S, Liu Z, Zhu J, Wood T, Hendrickson S, Oehler C, Garcia B, Spiegelman VS. Elcheva I, et al. Toxicol In Vitro. 2019 Dec;61:104622. doi: 10.1016/j.tiv.2019.104622. Epub 2019 Aug 9. Toxicol In Vitro. 2019. PMID: 31404653 Free PMC article.

9

CRD-BP protects the coding region of betaTrCP1 mRNA from miR-183-mediated degradation.

Elcheva I, Goswami S, Noubissi FK, Spiegelman VS. Elcheva I, et al. Mol Cell. 2009 Jul 31;35(2):240-6. doi: 10.1016/j.molcel.2009.06.007. Mol Cell. 2009. PMID: 19647520 Free PMC article.

10

Overexpression of mRNA-binding protein CRD-BP in malignant melanomas.

Elcheva I, Tarapore RS, Bhatia N, Spiegelman VS. Elcheva I, et al. Oncogene. 2008 Aug 28;27(37):5069-74. doi: 10.1038/onc.2008.141. Epub 2008 May 5. Oncogene. 2008. PMID: 18454174

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters